Pharmacia Securities Class Action Lawsuit Settlement

In 2004 Pfizer acquired Pharmacia Corporation in large part of Pharmacia’s drug Celebrex.  At the time a securities class action against Pharmacia was ongoing in which shareholders alleged that Pharmacia violated federal securities laws in connection with its publication of gastrointestinal data from a Celebrex study.  After ten years of litigation, Pfizer settled the securities class action for $164 million.

Who can submit a claim?

Only investors who purchased or otherwise acquired Pharmacia common stock between April 17, 2000 and August 5, 2001 are eligible to make a claim as part of the settlement.

How to submit a claim?

An investor must complete a claim form and submit it as instructed.  A Proof of Claim form provided as a link to this page.

Deadline to file a Proof of Claim.

Investors must submit a Proof of Claim form by January 28, 2013.

Please note that Morgan & Morgan was not involved in this litigation.  We do not represent you or any class members.  We are however happy to provide the Proof of Claim forms or answer any questions you may have about the settlement.  Please complete the form on this page.